Identification of a predominant isolate of Mycobacterium tuberculosis using molecular and clinical epidemiology tools and in vitro cytokine responses

BMC Infectious Diseases

Volumn 3, Issue , 2003, Pages

  Sharma, Meenu Kaushal ^a,b   Al Azem, A ^a   Wolfe, Joyce ^b   Hershfield, E ^a,c   Kabani, A ^a,c  

^a HEALTH SCIENCES CENTRE   (Canada)

^b HEALTH CANADA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ABORIGINE; ADULT; ANTIBODY TITER; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; DATA BASE; DEMOGRAPHY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOASSAY; IN VITRO STUDY; INCIDENCE; LUNG CAVITY; MAJOR CLINICAL STUDY; MOLECULAR TYPING; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT INFORMATION; POPULATION RESEARCH; PREVALENCE; RESPIRATORY TRACT DISEASE; STRAIN DIFFERENCE; THORAX RADIOGRAPHY;

ADULT; BACTERIAL TYPING TECHNIQUES; CLINICAL LABORATORY TECHNIQUES; CYTOKINES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; MANITOBA; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2442680356     PISSN: 14712334     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2334-3-3     Document Type: Article

References (41)

1. Fanning EA Globalization of tuberculosis [editorial; comment] CMAJ 1998, 158:611-612
2. Raviglione MC, Sudre P, Rieder HL, Spinaci S and Kochi A Secular trends of tuberculosis in western Europe Bull World Health Organ 1993, 71(3-4):297-306
3. Al-Azem A, Elliot L, Hershfield E, Blackwood K and Kabani A Conventional and Molecular Epidemiology of Tuberculosis in Manitoba Int J Tuberc Lung Dis 2002,
4. Al-Azem AA, Hershfield ES, Sharma M, Wolfe J, Macmorran J, Hoban DJ and Kabani A Clinical and Molecular Epidemiology of Tuberculosis in Manitoba Community-Acquired Infections and Related Epidemiological Studies 2000, 585-585
5. Long R, Njoo H and Hershfield E Tuberculosis: 3. Epidemiology of the disease in Canada CMAJ 1999, 160:1185-1190
6. Long R, Sutherland K, Kunimoto D, Cowie R and Manfreda J The epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: identification of high risk groups Int J Tuberc Lung Dis 2002, 6:615-621
7. Cohn DL and O'Brien RJ The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries Int J Tuberc Lung Dis 1998, 2:16-26
8. Small PM, Hopewell PC, Samir MD, Singh P, Paz A, Parsonnet J, Ruston DC, Gisela BS, Schecter F, Daley CL and Schoolnik G A Population-Based Study Using Conventional and Molecular Methods New England Journal of Medicine 9940, 330:1703-1709
9. Clarridge JE III, Shawar RM, Shinnick TM and Plikaytis BB Largescale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory J Clin Microbiol 1993, 31:2049-2056
10. van-Soolingen D, Qian L, de-Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P and van-Embden JD Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia J Clin Microbiol 1995, 33:3234-3238
11. van-Soolingen D, Hermans PW, de-Haas PE, Soll DR and van-Embden JD Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis J Clin Microbiol 1991, 29:2578-2586
12. Chevrel DD, Abderrahman A, Haltiti R, Koubaji H, Gicquel B and Dellagi K Large-scale DNA fingerprinting of Mycobacterium tuberculosis strains as a tool for epidemiological studies of tuberculosis J Clin Microbiol 1993, 31:2446-2450
13. Eisenach KD, Crawford JT and Bates JH Genetic Relatedness among Sttrains of the Mycobacterium tuberculosis Complex Am Rev Respir Dis 1986, 1065-1068
14. Soini H, Pan X, Teeter L, Musser JM and Graviss EA Transmission dynamics and molecular characterization of Mycobacterium tuberculosis isolates with low copy numbers of IS6110 Journal Of Clinical Microbiology 1901, 39:217-221
15. Barnes PF, Chatterjee D, Abrams JS, Lu S, Wang E, Yamamura M, Brennan PJ and Modlin RL Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure J Immunol 1992, 149:541-547
16. Barnes PF and Modlin RL Human cellular immune responses to Mycobacterium tuberculosis Curr Top Microbiol Immunol 1996, 215:197-219
17. Skamene E, Schurr E and Gros P Infection genomics: Nramp1 as a major determinant of natural resistance to intracellular infections Annu Rev Med 1998, 49:275-287
18. Qureshi ST, Skamene E and Malo D Comparative genomics and host resistance against infectious diseases Emerg Infect Dis 1999, 5:36-47
19. Lucey DR, Clerici M and Shearer GM Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases Clin Microbiol Rev 1996, 9:532-562
20. Elliott AM, Hurst TJ, Balyeku MN, Quigley MA, Kaleebu P, French N, Biryahwaho B, Whitworth JA, Dockrell HM and Hayes RJ The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study Int J Tuberc Lung Dis 1999, 3:239-247
21. Flesch IE and Kaufmann SH Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor Infect Immun 1990, 58:2675-2677
22. van-Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, Hermans P, Martin C, McAdam R and Shinnick TM Strain identification of Mycobacterium tuberculosis by DNA finger-printing: recommendations for a standardized methodology [see comments] J Clin Microbiol 1993, 31:406-409
23. Zimmerli S, Edwards S and Ernst JD Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages Am J Respir Cell Mol Biol 1996, 15:760-770
24. Fulton SA, Johnsen JM, Wolf SF, Sieburth DS and Boom WH Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis Infect Immun 1996, 64:2523-2531
25. Aso H, Yoshite O, Tomioka Y, Rose MT and Mizugaki M A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1 Microbiol Immunol 1999, 43:53-59
26. Valway SE, Sanchez MPC, Shinnick TF, Orme I, Agerton T, Hoy D, Jones S, Westmoreland H and Onorato M An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis N Engl J Med 1998, 338:633-638
27. Arvanitakis Z, Long RL, Hershfield ES, Manfreda J, Kabani A, Kunimoto D and Power C M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence Neurology 1998, 50:1827-1832
28. Manca C, Tsenova L, Barry CE, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH and Kaplan G Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates J Immunol 1999, 162:6740-6746
29. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE III, Freedman VH and Kaplan G Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta Proc Natl Acad Sci U S A 2001, 98:5752-5757
30. Flesch IE, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H and Kaufmann SH Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha J Exp Med 1995, 181:1615-1621
31. Romani L, Puccetti P and Bistoni F Interleukin-12 in infectious diseases Clin Microbiol Rev 1997, 10:611-636
32. Chan J, Xing Y, Magliozzo RS and Bloom BR Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages J Exp Med 1992, 175:1111-1122
33. Flesch IE and Kaufmann SH Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates Infect Immun 1991, 59:3213-3218
34. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA and Bloom BR An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J Exp Med 1993, 178:2249-2254
35. Chensue SW, Warmington KS, Ruth JH, Lincoln P and Kunkel SL Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF J Immunol 1995, 154:5969-5976
36. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG and Orme IM Disseminated tuberculosis in interferon gamma gene-disrupted mice J Exp Med 1993, 178:2243-2247
37. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW and Bloom BR Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice Immunity 1995, 2:561-572
38. Johnson BJ and McMurray DN Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes Infect Immun 1994, 62:1444-1450
39. Bogdan C, Vodovotz Y and Nathan C Macrophage deactivation by interleukin 10 J Exp Med 1991, 174:1549-1555
40. Zhang M, Gong J, Yang Z, Samten B, Cave MD and Barnes PF Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages J Infect Dis 1999, 179:1213-1217
41. Barnes PF and Wizel B Type 1 cytokines and the pathogenesis of tuberculosis American Journal Of Respiratory And Critical Care Medicine 2000, 161:1773-1774